Selected research
Industry Research
Cognitive Behavioral Therapy for Insomnia Industry Research Report 2026
Market perspective
The global Cognitive Behavioral Therapy for Insomnia market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cognitive Behavioral Therapy for Insomnia market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cognitive Behavioral Therapy for Insomnia market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cognitive Behavioral Therapy for Insomnia market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cognitive Behavioral Therapy for Insomnia include MINERVA NEUROSCIENCES INC, CURRAX PHARMACEUTICALS LLC, Pfizer Inc., Sanofi, zydus cadila, Vanda Pharmaceuticals Inc., EISAI,, merck kgaa and darmstadt, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cognitive Behavioral Therapy for Insomnia market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cognitive Behavioral Therapy for Insomnia.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cognitive Behavioral Therapy for Insomnia Market by Company
MINERVA NEUROSCIENCES INC
CURRAX PHARMACEUTICALS LLC
Pfizer Inc.
Sanofi
zydus cadila
Vanda Pharmaceuticals Inc.
EISAI,
merck kgaa
darmstadt
germany
VIATRIS INC
Takeda Pharmaceutical Company
Cognitive Behavioral Therapy for Insomnia Segment by Type
Non Pharmacological Therapy
Pharmacological Therapy
Cognitive Behavioral Therapy for Insomnia Segment by Application
Mental Health Services
Sleep Clinics
Pharmaceutical Industry
Sleep-related Devices and Technology
Cognitive Behavioral Therapy for Insomnia Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Behavioral Therapy for Insomnia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cognitive Behavioral Therapy for Insomnia and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Behavioral Therapy for Insomnia.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cognitive Behavioral Therapy for Insomnia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Non Pharmacological Therapy
- Pharmacological Therapy
Applications
- Mental Health Services
- Sleep Clinics
- Pharmaceutical Industry
- Sleep-related Devices and Technology
Companies covered
- MINERVA NEUROSCIENCES INC
- CURRAX PHARMACEUTICALS LLC
- Pfizer Inc.
- Sanofi
- zydus cadila
- Vanda Pharmaceuticals Inc.
- EISAI,
- merck kgaa
- darmstadt
- germany
- VIATRIS INC
- Takeda Pharmaceutical Company
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cognitive Behavioral Therapy for Insomnia by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Non Pharmacological Therapy
- 2.2.3 Pharmacological Therapy
- 2.3 Cognitive Behavioral Therapy for Insomnia by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Mental Health Services
- 2.3.3 Sleep Clinics
- 2.3.4 Pharmaceutical Industry
- 2.3.5 Sleep-related Devices and Technology
- 2.4 Assumptions and Limitations
3 Cognitive Behavioral Therapy for Insomnia Breakdown Data by Type
- 3.1 Global Cognitive Behavioral Therapy for Insomnia Historic Market Size by Type (2021-2026)
- 3.2 Global Cognitive Behavioral Therapy for Insomnia Forecasted Market Size by Type (2027-2032)
4 Cognitive Behavioral Therapy for Insomnia Breakdown Data by Application
- 4.1 Global Cognitive Behavioral Therapy for Insomnia Historic Market Size by Application (2021-2026)
- 4.2 Global Cognitive Behavioral Therapy for Insomnia Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cognitive Behavioral Therapy for Insomnia Market Perspective (2021-2032)
- 5.2 Global Cognitive Behavioral Therapy for Insomnia Growth Trends by Region
- 5.2.1 Global Cognitive Behavioral Therapy for Insomnia Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cognitive Behavioral Therapy for Insomnia Historic Market Size by Region (2021-2026)
- 5.2.3 Cognitive Behavioral Therapy for Insomnia Forecasted Market Size by Region (2027-2032)
- 5.3 Cognitive Behavioral Therapy for Insomnia Market Dynamics
- 5.3.1 Cognitive Behavioral Therapy for Insomnia Industry Trends
- 5.3.2 Cognitive Behavioral Therapy for Insomnia Market Drivers
- 5.3.3 Cognitive Behavioral Therapy for Insomnia Market Challenges
- 5.3.4 Cognitive Behavioral Therapy for Insomnia Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cognitive Behavioral Therapy for Insomnia Players by Revenue
- 6.1.1 Global Top Cognitive Behavioral Therapy for Insomnia Players by Revenue (2021-2026)
- 6.1.2 Global Cognitive Behavioral Therapy for Insomnia Revenue Market Share by Players (2021-2026)
- 6.2 Global Cognitive Behavioral Therapy for Insomnia Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cognitive Behavioral Therapy for Insomnia Head Office and Area Served
- 6.4 Global Cognitive Behavioral Therapy for Insomnia Players, Product Type & Application
- 6.5 Global Cognitive Behavioral Therapy for Insomnia Manufacturers Established Date
- 6.6 Global Cognitive Behavioral Therapy for Insomnia Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032)
- 7.2 North America Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 7.4 North America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032)
- 8.2 Europe Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 8.4 Europe Cognitive Behavioral Therapy for Insomnia Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032)
- 9.2 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cognitive Behavioral Therapy for Insomnia Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032)
- 10.2 South America Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 10.4 South America Cognitive Behavioral Therapy for Insomnia Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size (2021-2032)
- 11.2 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cognitive Behavioral Therapy for Insomnia Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 MINERVA NEUROSCIENCES INC
- 12.1.1 MINERVA NEUROSCIENCES INC Company Information
- 12.1.2 MINERVA NEUROSCIENCES INC Business Overview
- 12.1.3 MINERVA NEUROSCIENCES INC Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.1.4 MINERVA NEUROSCIENCES INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.1.5 MINERVA NEUROSCIENCES INC Recent Developments
- 12.2 CURRAX PHARMACEUTICALS LLC
- 12.2.1 CURRAX PHARMACEUTICALS LLC Company Information
- 12.2.2 CURRAX PHARMACEUTICALS LLC Business Overview
- 12.2.3 CURRAX PHARMACEUTICALS LLC Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.2.4 CURRAX PHARMACEUTICALS LLC Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.2.5 CURRAX PHARMACEUTICALS LLC Recent Developments
- 12.3 Pfizer Inc.
- 12.3.1 Pfizer Inc. Company Information
- 12.3.2 Pfizer Inc. Business Overview
- 12.3.3 Pfizer Inc. Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.3.4 Pfizer Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.3.5 Pfizer Inc. Recent Developments
- 12.4 Sanofi
- 12.4.1 Sanofi Company Information
- 12.4.2 Sanofi Business Overview
- 12.4.3 Sanofi Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.4.4 Sanofi Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.4.5 Sanofi Recent Developments
- 12.5 zydus cadila
- 12.5.1 zydus cadila Company Information
- 12.5.2 zydus cadila Business Overview
- 12.5.3 zydus cadila Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.5.4 zydus cadila Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.5.5 zydus cadila Recent Developments
- 12.6 Vanda Pharmaceuticals Inc.
- 12.6.1 Vanda Pharmaceuticals Inc. Company Information
- 12.6.2 Vanda Pharmaceuticals Inc. Business Overview
- 12.6.3 Vanda Pharmaceuticals Inc. Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.6.4 Vanda Pharmaceuticals Inc. Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.6.5 Vanda Pharmaceuticals Inc. Recent Developments
- 12.7 EISAI,
- 12.7.1 EISAI, Company Information
- 12.7.2 EISAI, Business Overview
- 12.7.3 EISAI, Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.7.4 EISAI, Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.7.5 EISAI, Recent Developments
- 12.8 merck kgaa
- 12.8.1 merck kgaa Company Information
- 12.8.2 merck kgaa Business Overview
- 12.8.3 merck kgaa Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.8.4 merck kgaa Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.8.5 merck kgaa Recent Developments
- 12.9 darmstadt
- 12.9.1 darmstadt Company Information
- 12.9.2 darmstadt Business Overview
- 12.9.3 darmstadt Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.9.4 darmstadt Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.9.5 darmstadt Recent Developments
- 12.10 germany
- 12.10.1 germany Company Information
- 12.10.2 germany Business Overview
- 12.10.3 germany Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.10.4 germany Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.10.5 germany Recent Developments
- 12.11 VIATRIS INC
- 12.11.1 VIATRIS INC Company Information
- 12.11.2 VIATRIS INC Business Overview
- 12.11.3 VIATRIS INC Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.11.4 VIATRIS INC Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.11.5 VIATRIS INC Recent Developments
- 12.12 Takeda Pharmaceutical Company
- 12.12.1 Takeda Pharmaceutical Company Company Information
- 12.12.2 Takeda Pharmaceutical Company Business Overview
- 12.12.3 Takeda Pharmaceutical Company Revenue in Cognitive Behavioral Therapy for Insomnia Business (2021-2026)
- 12.12.4 Takeda Pharmaceutical Company Cognitive Behavioral Therapy for Insomnia Product Portfolio
- 12.12.5 Takeda Pharmaceutical Company Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst